Skip to main content

Advertisement

Log in

Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma

Serum-Antikörper gegen Gruppenantigene bakterieller Lipopolysaccharide bei gesunden Erwachsenen und bei Patienten mit multiplem Myelom

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

The incidence of infections caused by gramnegative bacteria is increased in patients with multiple myeloma due to secondary humoral immunodeficiency. In order to diagnose patients with increased susceptibility to gram-negative infections, serum antibodies against common determinants of lipopolysaccharides (lipid A and core-polysaccharide) were determined by a rapid enzyme-linked immunosorbent assay (ELISA). It was possible to define a group of patients at high risk of contracting gram-negative infections using this test. Intravenous IgG preparations used as a substitute were shown to contain antibodies against these common antigens. However, it is suggested that the clinically recognized efficacy of these preparations could be due to their containing anti-LPS antibodies.

Zusammenfassung

Aufgrund ihres sekundären humoralen Immundefektes treten bei Patienten mit multiplem Myelom gehäuft Infektionen durch gramnegative Bakterien auf. Um Patienten mit einer erhöhten Anfälligkeit für gramnegative Infektionen zu diagnostizieren, wurden die Serum-Antikörper gegen gemeinsame Determinanten der Lipopolysaccharide (Lipid A und zentrales Polysaccharid) in einem schnellen enzymverbundenen Immunbindungstest (ELISA) bestimmt. Mit diesem Test-system war es möglich, eine Gruppe von Patienten mit einem hohen Risiko für gramnegative Infektionen zu definieren. Es wurde gezeigt, daß IgG-Präparationen, die zur intravenösen Substitution verwendet werden, Antikörper gegen diese gemeinsamen Antigene enthalten. Dabei ist zu vermuten, daß die klinisch gefundene Wirksamkeit dieser Präparationen auf ihrem Gehalt an anti-LPS-Antikörpern beruhen könnte.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Barandun, S., Morell, A., Skvaril, F., Keller, H. Immunopertubation in paraproteinemia. Birth Defects (Original Article Series) 11 (1975) 95–98.

    Google Scholar 

  2. Cohen, H. J., Rundles, R. W. Managing the complications of plasma cell myeloma. Arch. Intern. Med. 135 (1975) 177–184.

    Article  CAS  PubMed  Google Scholar 

  3. Schedel, I. Intravenöse Immunglobulinsubstitution bei Patienten mit multiplem Myelom, Morbus Waldenström und chronischer lymphatischer Leukämie. In:Schmidt, R. E., Stroehmann, I. (eds.): Immunglobulintherapie — Grundlagen und klinische Anwendung. Karger, Basel 1983, pp. 52–58.

    Google Scholar 

  4. Twomey, J. J. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch. Intern. Med. 132 (1973) 562–565.

    Article  CAS  PubMed  Google Scholar 

  5. Meyers, B. R., Hirschman, S. Z., Axelrod, J. A. Current patterns of infection in multiple myeloma. Am. J. Med. 52 (1972) 87–92.

    Article  CAS  PubMed  Google Scholar 

  6. Galanos, C. Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component. Z. Immunitätsforsch. Immunobiol. 149 (1975) 214–229.

    CAS  Google Scholar 

  7. Galanos, C., Freudenberg, M. A., Hase, S., Jay, F., Ruschmann, E. Biological activities and immunological properties of lipid A. In:Schlessinger, D. (ed.): Microbiology. American Society for Microbiology, Washington D. C. 1977, pp. 269–276.

    Google Scholar 

  8. Galanos, C., Lüderitz, O., Rietschel, E. T., Westphal, O. Newer aspects of the chemistry and biology of bacterial polysaccharides, with special reference to their lipid A component. Int. Rev. Biochem. 14 (1977) 239–335.

    CAS  Google Scholar 

  9. Galanos, C., Lüderitz, O., Westphal, O. Preparation and properties of antisera against the lipid A component of bacterial lipopolysaccharides. Eur. J. Biochem. 24 (1971) 116–122.

    Article  CAS  PubMed  Google Scholar 

  10. Galanos, C., Freudenberg, M. A., Jay, F. A., Nerkar, D., Veleva, K., Brade, H., Strittmatter, W. Immunogenic properties of lipid A. Rev. Infect. Dis. 6 (1984) 546–552.

    Article  CAS  PubMed  Google Scholar 

  11. Fink, P. C., Galanos, C. Determination of anti-lipid A and lipid A by enzyme immunoassay. Immunobiology 158 (1981) 380–390.

    Article  CAS  PubMed  Google Scholar 

  12. Mattsby-Baltzer, I., Alving, C. R. Antibodies to lipid A: occurrence in humans. Rev. Infect. Dis. 6 (1984) 553–557.

    Article  CAS  PubMed  Google Scholar 

  13. Durie, B. G., Salmon, S. E. A clinical staging system for multiple myeloma. Cancer 36 (1975) 842–854.

    Article  CAS  PubMed  Google Scholar 

  14. Engvall, E., Perlmann, P. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tube. J. Immunol. 109 (1972) 129–135.

    PubMed  CAS  Google Scholar 

  15. Peest, D., Holm, G., Mellstedt, H., Petterson, D. In vitro production of monoclonal and polyclonal immunoglobulins by peripheral blood mononuclear cells in human plasma cell myeloma. Scand. J. Immunol. 15 (1982) 595–603.

    Article  CAS  PubMed  Google Scholar 

  16. Marget, W., Weiß, M., Ruhland, B. Lipid A antibody determinations using ELISA on patients at a children's hospital: a preliminary report. Infection 11 (1983) 84–86.

    Article  CAS  PubMed  Google Scholar 

  17. Mattsby-Baltzer, I., Claesson, I., Hanson, L. A., Jodal, U., Kaijser, B., Lindberg, U., Peterson, H. Antibodies to lipid A during urinary tract infection. J. Infect. Dis. 144 (1981) 319–328.

    Article  CAS  PubMed  Google Scholar 

  18. Ahlstedt, S., Carlsson, B., Hanson, L. Å., Kaijser, B., Mattsby-Baltzer, I., Sohl-Akerlund, A. Applications of the ELISA for determination of immunoglobulin class specificEscherichia coli antibodies. Scand. J. Immunol. (Suppl.) 7 (1978) 119–124.

    Article  CAS  Google Scholar 

  19. Mattsby-Baltzer, I., Kaijser, B. Lipid A and anti-lipid A. Infect. Immun. 23 (1979) 758–763.

    PubMed  PubMed Central  CAS  Google Scholar 

  20. Salonen, E. M., Vaheri, A. Rapid solid-phase enzyme immunoassay for antibodies to viruses and other microbes: effects of polyethylene glycol. J. Immunol. Methods 41 (1981) 95–103.

    Article  CAS  PubMed  Google Scholar 

  21. Bruins, S. C., Stumacher, R., Johns, M. A., McCabe, W. R. Immunization with R mutants ofSalmonella minnesota. III. Comparison of the protective effect of immunization with lipid A and the Re mutant. Infect. Immun. 17 (1977) 16–20.

    PubMed  PubMed Central  CAS  Google Scholar 

  22. McCabe, W. R., Bruins, S. C., Craven, D. E., Johns, M. Cross-reactive antigens: their potential for immunization-induced immunity to gram-negative bacteria. J. Infect. Dis. (Suppl.) 136 (1977) 161–166.

    Article  Google Scholar 

  23. Mullan, N. A., Newsome, P. M., Cunnington, P. G., Palmer, G. H., Wilson, M. E. Protection against gram-negative infections with antiserum to lipid A fromSalmonella minnesota R595. Infect. Immun. 10 (1974) 1195–1201.

    PubMed  PubMed Central  CAS  Google Scholar 

  24. Mattsby-Baltzer, I., Hanson, L. Å., Olling, S., Kaijser, B. ExperimentalEscherichia coli ascending pyelonephritis in rats: active peroral immunization with liveEscherichia coli. Infect. Immun. 35 (1982) 647–653.

    PubMed  PubMed Central  CAS  Google Scholar 

  25. Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., Braude, A. I Treatment of gram-negative bacteremia and shock with human antiserum to a mutantEscherichia coli. N. Engl. J. Med. 307 (1982) 1225–1230.

    Article  CAS  Google Scholar 

  26. Rioux-Darrieulat, F., Parant, M., Chedid, L. Prevention of endotoxin-induced abortion by treatment of mice with antisera. J. Infect. Dis. 137 (1978) 7–13.

    Article  CAS  PubMed  Google Scholar 

  27. Rietschel, E. T., Galanos, C. Lipid A antiserum-mediated protection against lipopolysaccharide and lipid A-induced fever and skin necrosis. Infect. Immun. 15 (1977) 34–49.

    PubMed  PubMed Central  CAS  Google Scholar 

  28. Westenfelder, M., Galanos, C., Madson, P. O. Experimental lipid A-induced nephritis in the dog. Invest. Urol. 12 (1975) 337–345.

    PubMed  CAS  Google Scholar 

  29. Westenfelder, M., Galanos, C., Madson, P. O., Marget, W. Pathological activities of lipid A: Experimental studies in relation to chronic pyelonephritis. In:Schlessinger, D. (ed.): Microbiology. American Society for Microbiology, Washington D. C. 1977, pp. 277–279.

    Google Scholar 

  30. Lachman, E., Pitsoe, S. B., Gaffin, S. L. Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin. Lancet I (1984) 981–983.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoll, C., Schedel, I. & Peest, D. Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma. Infection 13, 115–119 (1985). https://doi.org/10.1007/BF01642869

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01642869

Keywords

Navigation